GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » P&K Skin Research Center Co Ltd (XKRX:347740) » Definitions » Equity-to-Asset

P&K Skin Research Center Co (XKRX:347740) Equity-to-Asset : 0.96 (As of Dec. 2023)


View and export this data going back to 2020. Start your Free Trial

What is P&K Skin Research Center Co Equity-to-Asset?

Equity to Asset ratio is calculated as total stockholders equity divided by total asset. P&K Skin Research Center Co's Total Stockholders Equity for the quarter that ended in Dec. 2023 was ₩74,203 Mil. P&K Skin Research Center Co's Total Assets for the quarter that ended in Dec. 2023 was ₩77,407 Mil. Therefore, P&K Skin Research Center Co's Equity to Asset Ratio for the quarter that ended in Dec. 2023 was 0.96.

The historical rank and industry rank for P&K Skin Research Center Co's Equity-to-Asset or its related term are showing as below:

XKRX:347740' s Equity-to-Asset Range Over the Past 10 Years
Min: 0.88   Med: 0.93   Max: 0.96
Current: 0.96

During the past 7 years, the highest Equity to Asset Ratio of P&K Skin Research Center Co was 0.96. The lowest was 0.88. And the median was 0.93.

XKRX:347740's Equity-to-Asset is ranked better than
99.16% of 237 companies
in the Medical Diagnostics & Research industry
Industry Median: 0.58 vs XKRX:347740: 0.96

P&K Skin Research Center Co Equity-to-Asset Historical Data

The historical data trend for P&K Skin Research Center Co's Equity-to-Asset can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

P&K Skin Research Center Co Equity-to-Asset Chart

P&K Skin Research Center Co Annual Data
Trend Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Equity-to-Asset
Get a 7-Day Free Trial 0.88 0.93 0.94 0.95 0.96

P&K Skin Research Center Co Quarterly Data
Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23
Equity-to-Asset Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.95 0.94 0.95 0.96 0.96

Competitive Comparison of P&K Skin Research Center Co's Equity-to-Asset

For the Diagnostics & Research subindustry, P&K Skin Research Center Co's Equity-to-Asset, along with its competitors' market caps and Equity-to-Asset data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


P&K Skin Research Center Co's Equity-to-Asset Distribution in the Medical Diagnostics & Research Industry

For the Medical Diagnostics & Research industry and Healthcare sector, P&K Skin Research Center Co's Equity-to-Asset distribution charts can be found below:

* The bar in red indicates where P&K Skin Research Center Co's Equity-to-Asset falls into.



P&K Skin Research Center Co Equity-to-Asset Calculation

Equity to Asset ratio measures the ratios of the portion of the asset owned by shareholders out of the total asset. It indicates the leverage of the company, and the amount of debt the company uses in its operation.

Equity to Asset ratio is calculated by dividing total stockholders equity by total asset.

P&K Skin Research Center Co's Equity to Asset Ratio for the fiscal year that ended in Dec. 2023 is calculated as

Equity to Asset (A: Dec. 2023 )=Total Stockholders Equity/Total Assets
=74203.218/77407.166
=0.96

P&K Skin Research Center Co's Equity to Asset Ratio for the quarter that ended in Dec. 2023 is calculated as

Equity to Asset (Q: Dec. 2023 )=Total Stockholders Equity/Total Assets
=74203.218/77407.166
=0.96

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


P&K Skin Research Center Co  (XKRX:347740) Equity-to-Asset Explanation

Equity to Asset ratio can vary greatly across different industries, as they have different capital structure. A company with smaller Equity to Asset ratio (more leveraged) may have higher ROE % because of the leverage.

For banks, the required minimum Equity to Asset ratio by regulation is 5%. Some stronger banks may have Equity to Asset Ratio of more than 10%.


P&K Skin Research Center Co Equity-to-Asset Related Terms

Thank you for viewing the detailed overview of P&K Skin Research Center Co's Equity-to-Asset provided by GuruFocus.com. Please click on the following links to see related term pages.


P&K Skin Research Center Co (XKRX:347740) Business Description

Traded in Other Exchanges
N/A
Address
National Assembly Road 62 -25 Yeongdeungpo-gu, Education Facility Disaster Relief Society Building, 4th Floor, Seoul, KOR, 07236
P&K Skin Research Center Co Ltd is a skin research center. It provides clinical tests for new cosmetics, raw materials, and cosmeceuticals. The company provides skin irritation tests, Stimulation tests, skin wrinkle evaluation, skin texture evaluation, skin whitening evaluation, sweat proof evaluation, skin density measurement, scalp flakiness evaluation, and hair root evaluation. Also, the company provides health food tests, sensory tests, and In Vitro tests.

P&K Skin Research Center Co (XKRX:347740) Headlines

No Headlines